报价延迟最少15分钟:2026/10/01 21:29 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
17.02 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.95/-0.82
|
|
企业价值
1.12B
|
| 资产负债 |
|
每股账面净值
5.94
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
224.50M
|
|
每股收益
2.03
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S. |
